This poster outlines research evaluating the impact and acceptability of using a Controlled Temperature Chain (CTC) for HPV vaccine delivery in Côte d’Ivoire. The study examines effects on coverage, equity, and programmatic efficiency compared to standard cold chain systems. It also explores provider and policymaker perceptions, logistical requirements, and cost-effectiveness. Findings aim to inform policy […]
Language: English - French
Reaching out of school girls with HPV vaccine using community outreach in Jigawa, Nigeria.
This poster highlights innovative community outreach strategies used during Nigeria’s 2023 HPV vaccine introduction in Jigawa State, targeting girls aged 9–14. The campaign combined fixed posts, school outreach, and community mobilization to address the high proportion of out-of-school girls. Adaptations included farm-based sessions during harvest, flexible schedules, and extended mop-up days. These approaches enabled 76% […]
Human papillomavirus (HPV) vaccine implementation in Abia State, Nigeria: Lessons learnt from vaccinations in schools.
This poster details Abia State’s experience during Nigeria’s first HPV vaccine rollout in 2023, targeting girls aged 9–14 through school and community outreach. It highlights social mobilization efforts, including engagement with over 3,500 schools and the Ministry of Education’s role in coordination. Key challenges included funding gaps, overlapping health programs, and school participation barriers. Lessons […]
Achieving success in new vaccines introduction through effective planning and establishment of readiness: A case study of Nigeria’s HPV vaccine introduction.
The poster presents Nigeria’s first large-scale HPV vaccine introduction targeting adolescent girls (9–14 years) in 2023. It details the structured planning phases, readiness assessments, and inter-sectoral coordination that enabled high campaign coverage. Findings highlight lessons from pre-implementation to integration into routine immunization, linking preparedness with success. Key outcomes include 80% coverage in phase 1 states […]